Gerwin Huls

Gerwin Huls is a Professor at the University Medical Center Groningen (UMCG) and leads the Onco-Immunology (O-I) research group within the Faculty of Medical Sciences. His work focuses on hematological malignancies, particularly acute myeloid leukemia (AML) and multiple myeloma, integrating immunotherapy and stem cell transplantation strategies.

• Key research areas: Myeloid malignancies, fitness assessment in AML, CD47/SIRPα axis inhibition, and donor lymphocyte infusions.
• Active in supervising PhD students like Jimena Alvarez Freile and Yusheng Lin.
• Recent articles address clinical outcomes in leukemia, high-dose therapy for myeloma, and European LeukemiaNet guidelines.
• Contact: g.huls@umcg.nl

His research aligns with UN Sustainable Development Goals for improved healthcare (SDG 3: Good Health and Well-being).